Exam 3 Review Flashcards
(107 cards)
Wafarin (Coumadin) MOA
Indirectly inhibits the functional activation of “newly formed” Vit K dependent clotting factors II, VII, IX, X and protein C & C by directly inhibiting VKORC1’s ability to provide GGCX with reduced Vit K
Clopidogrel (Plavix) MOA
ADP inhibitor (antiplatelet)
Inhibit ability of ADP to increase the up regulation of gpIIb/IIIA receptors on the platelet surface that are known to mediate platelet aggregation
*Irreversible inhibition
ASA MOA
Irreversible inhibition of COX thereby decreasing the production of thromboxane A2 for the life of the platelet
Reversal agent - Coumadin
Vitamin K
Reversal agent - heparin
FFP
Protamine sulfate
Goal INR on Coumadin
2-3
How long does it take the “average” patient on Coumadin to get to INR goal?
5-7 days
How much should INR rise per day?
0.2
Warfarin (Coumadin) DDI
Inhibitors of CYP2C9: bacterium and fluconazole
others: amiodarone and metronidazole
Anticoagulant in pregnancy - DOC
Heparin (Coumadin is teratogenic)
Monitoring parameters - Coumadin
INR, maybe PT
Monitoring parameters - UFH
PTT (Goal 1.5-2 x normal)
Renal function
BUN, Creat (if >20-30 –> GI bleed?)
blood in stool/urine
Monitoring parameters - LMWH
None
Lovenox dosing
1 mg/kg BID if CrCl >30
1 mg/kg QD if CrCl <30
Clopidogrel DDI
PPI (some are OTC so patients may be taking them without your knowledge)
Absence seizure DOC
Depakote or Valproate
Lennox Gastaut DOC
Lamotrigine (Lamictal)
Levetiracetam (Keppra)
Topiramate (Topamax)
Drugs that worsen absence seizures
Phenytoin, Phenobarbital and Carbemazepine
Phenobarbital reference range
15-35 mcg/mL
Phenytoin reference range
10-20 mcg/mL
Carbemazepine reference range
4-12 mcg/mL
Valproate reference range
50-120 mcg/mL
Ethosuximide reference range
60-100 mcg/mL
Valproate - Lamotrigine DDI
Valproate inhibits lamotrigine metabolism by inhibiting glucuronidation (phase II pathway)
Start lamotrigine lower (25mg)